Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Stefan Hantel"'
Autor:
Stefan Hantel, Matthew R. Weir, Audrey Koitka-Weber, Maximilian von Eynatten, Christoph Wanner, Gert Mayer, Bernard Zinman, Silvio E. Inzucchi, David Z.I. Cherney
Publikováno v:
Kidney International. 96:489-504
In patients with type 2 diabetes mellitus (T2DM) and cardiovascular (CV) disease, empagliflozin (EMPA) decreased progression of chronic kidney disease (CKD), likely via a reduction in intraglomerular pressure. Due to prevalent comorbidities, such as
Autor:
Gert J. Mayer, Christoph Wanner, Matthew R. Weir, Silvio E. Inzucchi, Audrey Koitka-Weber, Stefan Hantel, Maximilian von Eynatten, Bernard Zinman, David Z.I. Cherney
Publikováno v:
Kidney International. 97:213-214
Autor:
Gert J, Mayer, Christoph, Wanner, Matthew R, Weir, Silvio E, Inzucchi, Audrey, Koitka-Weber, Stefan, Hantel, Maximilian, von Eynatten, Bernard, Zinman, David Z I, Cherney
Publikováno v:
Kidney international. 96(2)
In patients with type 2 diabetes mellitus (T2DM) and cardiovascular (CV) disease, empagliflozin (EMPA) decreased progression of chronic kidney disease (CKD), likely via a reduction in intraglomerular pressure. Due to prevalent comorbidities, such as